Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,728.50
Bid: 1,727.00
Ask: 1,728.00
Change: 23.50 (1.38%)
Spread: 1.00 (0.058%)
Open: 1,705.00
High: 1,729.50
Low: 1,695.50
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 4-UK bribery investigation adds to Glencore's legal headaches

Thu, 05th Dec 2019 13:45

* Scope of SFO investigation is unclear

* DoJ is already investigating Glencore

* Share price down 9% to 3-year low

* Law firm plans legal action on behalf of investors
(Adds comments from sources, share price, lawsuit, dateline)

By Yadarisa Shabong, Julia Payne and Kirstin Ridley

LONDON, Dec 5 (Reuters) - The UK's Serious Fraud Office
(SFO) has launched a bribery investigation into Glencore
, adding to legal troubles that have hit the shares of
one of the world's biggest miners and commodity traders.

The SFO said on Thursday it had opened an investigaton into
suspicions of bribery in the conduct of business by the Glencore
group of companies, its officials, employees, agents and
associated persons in June. It declined to comment on the scope
of its inquiry.

The London-listed shares of Glencore, which has operations
in over 150 countries, fell 9% to 216.9 pence, their lowest
level in more than three years, knocking 2.6 billion pounds
($3.3 billion) off the company's market value.

Glencore, which was subpoenaed in July 2018 by the U.S.
Department of Justice over possible violations of the Foreign
Corrupt Practices Act relating to operations in Nigeria,
Venezuela and the Democratic Republic of Congo (DRC), said it
would cooperate with the investigation.

Two sources familiar with the matter said the SFO had
recently sought information relating to Glencore's involvement
in the DRC and its former business partner, Israeli billionaire
businessman Dan Gertler.

Reuters was unable to ascertain whether those enquiries were
part of the SFO's bribery probe.

A London-based spokesman for Gertler declined to comment.

Gertler was sanctioned by the United States in 2017 over
allegations he used his friendship with former DRC President
Joseph Kabila to secure sweetheart mining deals. He denied all
allegations of impropriety at the time.

Over the course of this year, Glencore's shares have fallen
more than 20%, pressured by broader concerns about safety and
sustainability in the DRC. Canada's regulatory authorities fined
a Glencore-controlled subsidiary last year after allegations of
inadequate financial disclosures in the DRC.

The legal difficulties have upset shareholders. Boies
Schiller Flexner, a London-based law firm, said it was mounting
a fully-funded legal action on behalf of institutional investors
against Glencore for damages that could exceed 1.0 billion
pounds.

Glencore's CEO Ivan Glasenberg told investors earlier this
week he expected to step down next year once a new management
team is in place.

The investigation is one of the most high-profile SFO probes
launched under Lisa Osofsky, a former FBI lawyer appointed
director last August, who has come under fire for abandoning
some of the agency's most prominent and lengthy probes.

The SFO dropped its investigations into aero engine maker
Rolls-Royce and drugs maker GlaxoSmithKline in
February and ended a seven-year, Libor benchmark interest rate
inquiry in February.

($1 = 0.7794 pounds)

(Additional reporting by Yadarisa Shabong in Bengaluru;
Alistair Smout, Barbara Lewis and Zandi Shabalala in London;
Editing by Jane Merriman and Elaine Hardcastle)

More News
Today 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more
30 Apr 2024 12:22

Sensodyne-maker Haleon to shut UK plant, 435 jobs to go

April 30 (Reuters) - Haleon, the world's largest standalone consumer healthcare firm, will shut its UK production site which makes Sensodyne toothpastes by 2026, leading to 435 job losses, a spokesperson said on Tuesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.